Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Prepaid Assets (2019 - 2025)

Vivos Therapeutics' Prepaid Assets history spans 7 years, with the latest figure at $774000.0 for Q4 2025.

  • Quarterly results put Prepaid Assets at $774000.0 for Q4 2025, down 1.15% from a year ago — trailing twelve months through Dec 2025 was $774000.0 (down 1.15% YoY), and the annual figure for FY2025 was $774000.0, down 1.15%.
  • Prepaid Assets for Q4 2025 was $774000.0 at Vivos Therapeutics, up from $565000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $2.3 million in Q1 2022 to a low of $475000.0 in Q1 2024.
  • The 5-year median for Prepaid Assets is $855313.5 (2021), against an average of $1.1 million.
  • The sharpest move saw Prepaid Assets soared 143.09% in 2022, then crashed 64.71% in 2024.
  • Year by year, Prepaid Assets stood at $1.6 million in 2021, then decreased by 8.06% to $1.4 million in 2022, then plummeted by 57.46% to $616000.0 in 2023, then grew by 27.11% to $783000.0 in 2024, then dropped by 1.15% to $774000.0 in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $774000.0, $565000.0, and $695000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.